Ulcerative Colitis Stocks List

Related Stock Lists: Autoimmune Diseases Medical Specialties Medicine Biopharmaceutical Abdominal Pain Crohn's Disease Biotechnology Colitis Diarrhea Immunology Inflammatory Bowel Disease Psoriasis Clinical Trial Health Pharmaceutical Industry Cancer Clinical Medicine Diabetes Digestive Diseases Drug Discovery

Recent Signals

Date Stock Signal Type
2020-05-22 BHC NR7 Range Contraction
2020-05-22 BHC NR7-2 Range Contraction
2020-05-22 GLPG Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-22 GLPG Stochastic Reached Oversold Weakness
2020-05-22 GLPG 50 DMA Support Bullish
2020-05-22 HCM Fell Below 200 DMA Bearish
2020-05-22 HCM MACD Bearish Signal Line Cross Bearish
2020-05-22 HCM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-22 HCM Fell Below 20 DMA Bearish
2020-05-22 HCM Bollinger Band Squeeze Range Contraction
2020-05-22 LXRX NR7 Range Contraction
2020-05-22 LXRX Crossed Above 20 DMA Bullish
2020-05-22 LXRX Crossed Above 50 DMA Bullish
2020-05-22 LXRX 180 Bullish Setup Bullish Swing Setup
2020-05-22 LXRX Bollinger Band Squeeze Range Contraction
2020-05-22 MCRB New 52 Week Closing High Bullish
2020-05-22 MCRB 180 Bullish Setup Bullish Swing Setup
2020-05-22 PRVB NR7 Range Contraction
2020-05-22 PRVB Narrow Range Bar Range Contraction
2020-05-22 PRVB MACD Bearish Signal Line Cross Bearish
2020-05-22 PTGX 1,2,3 Pullback Bullish Bullish Swing Setup
2020-05-22 PTGX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-22 VBLT Stochastic Buy Signal Bullish

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

More about Ulcerative Colitis